Considering metabolic effects when making breast cancer treatment decisions
- PMID: 20923041
Considering metabolic effects when making breast cancer treatment decisions
Comment on
-
Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy.Oncology (Williston Park). 2010 Aug;24(9):839-44. Oncology (Williston Park). 2010. PMID: 20923040 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
